Table 4. Renal and Hepatic Responses . #... | American Society of Hematology

Table 4.

Renal and Hepatic Responses

	#	Proteinuria (<150 mg/d)		Alkaline Phosphatase (<120 U/L)		Albumin (3.5-5.5 g/dL)		Creatinine (<1.5 mg/dL)
	#	Pre	Post	Pre	Post	Pre	Post	Pre	Post
A	6	11,370	1,573	124	108	2.3	4.0	1.0	0.9
	7	12,800	11,400	104	77	2.2	2.5	1.0	4.1
	11	9,234	8,293	90	64	2.2	2.3	0.7	0.9
	13	9,653	7,320	135	111	2.1	3.1	0.8	0.9
	22	6,030	421	146	194	1.7	2.7	0.9	1.2
	23	16,390	21,625	59	61	1.2	1.7	0.9	7.1
	24	16,400	7,560	96	80	1.9	3.7	1.1	1.3
B	5	645	102	184	113	5.1	4.9	1.3	1.4
	8	16,300	4,218	490	520	3.4	4.8	1.6	1.3
	10	2,880	1,135	1,280	551	3.3	3.9	0.8	0.9
	12	3,548	1,595	413	199	3.3	5.7	0.8	0.7
	17	23,595	2,728	2,820	586	1.3	3.9	0.5	0.7
C	14	3,542	992	362	278	4.0	5.1	1.5	1.7
	18	2,420	4,189	1,488	160	2.7	3.3	0.9	1.3

	#	Proteinuria (<150 mg/d)		Alkaline Phosphatase (<120 U/L)		Albumin (3.5-5.5 g/dL)		Creatinine (<1.5 mg/dL)
	#	Pre	Post	Pre	Post	Pre	Post	Pre	Post
A	6	11,370	1,573	124	108	2.3	4.0	1.0	0.9
	7	12,800	11,400	104	77	2.2	2.5	1.0	4.1
	11	9,234	8,293	90	64	2.2	2.3	0.7	0.9
	13	9,653	7,320	135	111	2.1	3.1	0.8	0.9
	22	6,030	421	146	194	1.7	2.7	0.9	1.2
	23	16,390	21,625	59	61	1.2	1.7	0.9	7.1
	24	16,400	7,560	96	80	1.9	3.7	1.1	1.3
B	5	645	102	184	113	5.1	4.9	1.3	1.4
	8	16,300	4,218	490	520	3.4	4.8	1.6	1.3
	10	2,880	1,135	1,280	551	3.3	3.9	0.8	0.9
	12	3,548	1,595	413	199	3.3	5.7	0.8	0.7
	17	23,595	2,728	2,820	586	1.3	3.9	0.5	0.7
C	14	3,542	992	362	278	4.0	5.1	1.5	1.7
	18	2,420	4,189	1,488	160	2.7	3.3	0.9	1.3

All of these patients had amyloid-related renal involvement, and patients in groups B and C had both renal and hepatic involvement. The patients in group A had predominant renal involvement, those in B predominant hepatic, and in C predominant cardiac involvement. The columns give pre- and post-therapy values for laboratory tests obtained for each patient, the post-therapy value being from the most recent follow-up. (Normal values)

View Large